US BANCORP \DE\ - HTG MOLECULAR DIAGNOSTICS IN ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q2 2016$5,0000.0%1,6810.0%0.00%
Q1 2016$5,000
-28.6%
1,6810.0%0.00%
Q4 2015$7,0001,6810.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 2,426,300$802,0000.74%
Cowen Prime Services LLC 1,411,500$466,0000.23%
GSA CAPITAL PARTNERS LLP 1,205,873$398,0000.07%
Nantahala Capital Management 5,113,958$1,690,0000.05%
HighMark Wealth Management LLC 80,000$26,0000.02%
Kalos Management, Inc. 72,858$24,0000.01%
Qube Research & Technologies Ltd 585,187$193,0000.00%
WINTON GROUP Ltd 190,146$63,0000.00%
Ironwood Financial, llc 1,571$1,0000.00%
Virtu Financial LLC 12,049$4,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders